1610043-18-9

Basic information

• Product Name: (S)-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-2,13-dioxo-11H-6-oxa-12-aza-1(2,5)-pyrrola-5(1,4)-benzenacyclotridecaphane-11-carboxamide
• Synonyms: (S)-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-2,13-dioxo-11H-6-oxa-12-aza-1(2,5)-pyrrola-5(1,4)-benzenacyclotridecaphane-11-carboxamide
• CAS NO: 1610043-18-9
• Molecular Weight: 503.598
• Mol File: 1610043-18-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (S)-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-2,13-dioxo-11H-6-oxa-12-aza-1(2,5)-pyrrola-5(1,4)-benzenacyclotridecaphane-11-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-2,13-dioxo-11H-6-oxa-12-aza-1(2,5)-pyrrola-5(1,4)-benzenacyclotridecaphane-11-carboxamide(1610043-18-9)
• EPA Substance Registry System: (S)-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-2,13-dioxo-11H-6-oxa-12-aza-1(2,5)-pyrrola-5(1,4)-benzenacyclotridecaphane-11-carboxamide(1610043-18-9)

Safety Data

• Hazardous Substances Data: 1610043-18-9(Hazardous Substances Data)

Upstream product

• 1610043-23-6 ethyl 5-(3-(4-(allyloxy)phenyl)propanoyl)-1H-pyrrole-2-carboxylate 
• 5597-50-2 3-(4-hydroxyphenyl)propionic acid methyl ester 
• 3182-95-4 L-Phenylalaninol 
• 2199-43-1 ethyl 1H-pyrrole-2-carboxylate 
• 219502-08-6 3-(4-allyloxyphenyl)propanoyl chloride 
• 6522-02-7 3-(4-(allyloxy)phenyl)propanoic acid 
• 6522-01-6 methyl 3-(4-allyloxyphenyl)propanoate 
• 1610043-30-5 methyl (S)-2,13-dioxo-1¹H-6-oxa-12-aza-1(2,5)-pyrrola-5(1,4)-benzenacyclotridecaphane-11-carboxylate 
• 1610043-27-0 methyl (2S)-2-[[5-[3-(4-allyloxyphenyl)propanoyl]-1H-pyrrole-2-carbonyl]amino]pent-4-enoate 
• 1610043-25-8 5-(3-(4-(allyloxy)phenyl)propanoyl)-1H-pyrrole-2-carboxylic acid 

Downstream Products

• 1610042-98-2 (S)-2,13-dioxo-N-((S)-1-oxo-3-phenylpropan-2-yl)-1¹H-6-oxa-12-aza-1(2,5)-pyrrola-5(1,4)-benzenacyclotridecaphane-11-carboxamide 

Relevant articles and documents

MACROCYCLIC COMPOUNDS AND USES THEREOF

The present invention relates to novel macrocyclic compounds of Formula I and their use as novel therapeutic agents for example as novel compounds used in methods of preventing and/or treating a disease, condition or state in a subject associated with dysregulation of protease activity and/or dysregulation of proteosome activity